BCL2 is a predictive marker of adjuvant CMF regimen in...

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients

K Bouchalova,M Cizkova,R Trojanec,V Koudelakova,L Radova…
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Breast Cancer Research
DOI:
10.1186/bcr3029
Date:
December, 2011
File:
PDF, 186 KB
english, 2011
Conversion to is in progress
Conversion to is failed